Pelex
Pelex is developing a biofeedback device, consisting of a garment with embedded sensors and a downloadable software program, allowing users to perform biofeedback anywhere. Pelex Team: Jeremy Wiygul
Read MoreMEaDvise
MEaDvise improves pre-diabetic and diabetic patients’ outcomes and reduces the cost for insurers and individuals through personalized risk identification, care coordination, and digital health intervention. MEaDvise Team: Abbas Shojaee
Read MoreRevMedica
With the aim to disrupt the MIS-stapling $4.3B market, RevMedica is redefining the Operating Room value stream by creating the world’s first powered and reusable surgical-devices that do not require cleaning or sterilization. RevMedica Team: Rob Satti Thomas Wenchell
Read MoreImmersive Shift Labs
EnVision is a software that improves communication, diagnostics & surgery accuracy by manipulating real patient images in holographic 3D using mixed reality technology. Immersive Shift Labs Team: Mahmoud Morshedy
Read MoreEnrich Therapeutics
Enrich Therapeutics: The next-generation, image-based single-cell sorter. Enrich Therapeutics Team: Xueqi Liu Qi Zhao
Read MoreMIDA Project
MIDA Project is developing a high throughput screen test for detection of MVID among patients with diarrhea. MIDA Project Team: Ludmilla Kvochina
Read MoreKrouzon Pharmaceuticals, Inc.
Krouzon Pharmaceuticals, Inc. is developing a first-in-class treatment for ultra-rare orphan pediatric skeletal disorders. Krouzon Pharmaceuticals, Inc. Team: Jacob V. P. Eswarakumar
Read MoreDeMay Bio
DeMay Bio is developing a biologic drug for Rheumatoid Arthritis that leverages a natural human protein to target a novel, but validated, disease mechanism directly in the joints. The new drug is an adjunct therapy, to be used alongside a patient’s immunosuppressant regimen, to achieve better disease control, and to reduce disabling joint pain, tissue…
Read MoreELIV5
ELIV5 Therapeutics aims to develop a new class of antifungal drugs that target a critical step in fungal metabolism required for pathogen survival and virulence. ELIV5 Team: Choukri Ben Mamoun
Read MoreCalRegen, Inc.
CalRegen, Inc is a start-up biotechnology company formed on the discovery of calreticulin (CRT), as a novel biotherapeutic that has unique, diverse and broad ranging tissue regenerative qualities that will be developed for different indications including chronic wound healing, epidermal appendage (hair follicle) neogenesis, improving the cosmetic architecture of the skin, and healing of ophthalmic ulcers.…
Read More